Editas Medicine to Present Pre-clinical Data Demonstrating Progression of in vivo Medicines Pipeline at the American Society of Gene and Cell Therapy Annual Meeting

1d ago

EDIT

PremiumPress Releases

Editas Medicine Announces Fourth Quarter and Full Year 2023 Results and Business Updates

2M ago

EDIT

PremiumPress Releases

Editas Medicine Announces Fourth Quarter and Full Year 2023 Results Conference Call and Upcoming Investor Events

2M ago

EDIT

PremiumPre-Earnings

Is EDIT a Buy, Before Earnings?

2M ago

EDIT

PremiumPress Releases

Editas Medicine Highlights 2024 Anticipated Milestones and Strategic Priorities at the J.P. Morgan Healthcare Conference

4M ago

EDIT

PremiumPress Releases

Editas Medicine and Vertex Pharmaceuticals Enter into Non-exclusive License Agreement for Cas9

4M ago

EDIT

PremiumPress Releases

Editas Medicine Announces New EDIT-301 Safety and Efficacy Data in 17 Patients, Presented Today at the American Society of Hematology (ASH) Annual Meeting and in a Company-sponsored Webinar

4M ago

EDIT

More EDIT News >

8EM News on the Web

2024-04-22

Editas Medicine to Present Pre-clinical Data Demonstrating Progression of in vivo Medicines Pipeline at the American Society of Gene and Cell Therapy Annual Meeting

Yahoo Finance

Neutral

2024-03-29

Why Is Editas Down 26.2% Since Last Earnings Report?

Yahoo Finance

Neutral

2024-03-29

Why Is Editas (EDIT) Down 26.2% Since Last Earnings Report?

Zacks

Neutral

2024-03-26

Analyst Rating: Will Editas Medicine Inc (EDIT) Stock Do Better Than the Market?

Investors Observer

Neutral

2024-03-19

Is Editas Medicine Inc (EDIT) a Stock to Watch After Losing 0.00% This Week?

Investors Observer

Neutral

2024-03-13

Analyst Rating: Will Editas Medicine Inc (EDIT) Stock Beat the Market?

Investors Observer

Neutral

2024-03-11

Can Editas Medicine Inc (EDIT) Stock Rise to the Top of Healthcare Sector Monday?

Investors Observer

Neutral

2024-03-07

1 Wall Street Analyst Raises Editas Medicine's Price Target by 45%. Here's Why She's Right.

Motley Fool

Neutral

News Score - Last 7 Days

Neutral

DE:8EM

Sector Average

Media Buzz

This Week1 articles

Weekly Average1 articles

News Sentiment

This Week50%

Sector Average58%

See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is DE:8EM’s Media Buzz Sentiment?

1 articles about DE:8EM were published this week. In an average week, 1 articles are published.

What is DE:8EM’s weekly average amount of articles?

In an average week, 1 articles about DE:8EM are published.

What is DE:8EM’s News Sentiment?

50% of articles about DE:8EM were positive this week, compared to its sector average of 58%.

Healthcare Stocks that are Trending in the News

IMVTImmunovant

INSPInspire Medical Systems

EVOEvotec AG

ISRGIntuitive Surgical

ABTAbbott Labs

Showing the stocks with the most bullish news sentiment over the past week

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing